ReviewJournal of hematology & oncology2022

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias.

Yan Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.